...
首页> 外文期刊>Rapid Communications in Mass Spectrometry: RCM >Quantification of human insulin-like growth factor-1 and qualitative detection of its analogues in plasma using liquid chromatography/electrospray ionisation tandem mass spectrometry
【24h】

Quantification of human insulin-like growth factor-1 and qualitative detection of its analogues in plasma using liquid chromatography/electrospray ionisation tandem mass spectrometry

机译:血浆中人胰岛素样生长因子-1的定量分析及其类似物的液相色谱/电喷雾电离串联质谱检测

获取原文
获取原文并翻译 | 示例

摘要

Human insulin-like growth factor-1 (IGF-1) is a peptide hormone that acts as a mediator of most of the somatotropic effects of growth hormone (GH). Therefore, it is supposed to be a biomarker indicating GH abuse in sports as well as diseases associated with a change in IGF-1 plasma concentration. It can be applied locally by injection to increase total protein and DNA content in tissues such as skeletal muscle - a highly desirable effect in various sports disciplines. In order to improve its growth-promoting properties, the primary structure of IGF-1 has been modified, yielding analogues such as des(1-3)IGF-1 and LONG (TM) R-3 IGF-1, which show a considerably reduced affinity to the respective binding proteins in plasma and, thus, an increased bioavailability at target tissues. Due to their capability to enhance performance, IGF-1 and its analogues belong to the prohibited list of the World Anti-Doping Agency. Hence, it was necessary to develop a reliable assay for the quantification of human IGF-1 as well as the detection of its derivatives. Immunoaffinity isolation and purification from 60 mu L of plasma followed by liquid chromatography/electrospray ionisation tandem mass spectrometry enabled the unequivocal determination of all target analytes. Diagnostic product ions were characterised utilising an Orbitrap mass spectrometer with high resolution/high accuracy properties and employed for triple quadrupole MS/MS analysis. The described assay provided lower limits of detection (LLODs) between 20 and 50 ng/mL, recovery rates between 34-43% and a precision <15% at the LLOD as well as higher concentration levels. In order to prove the applicability of the developed assay, human plasma samples were analysed and the results were compared with the values obtained from a commercially available immunoradiometric assay (IRMA). Four of six samples resulted in concentration ratios with good correlation between both assays, whereas the absolute concentrations were lower for the presented procedure. Copyright (C) 2008 John Wiley & Sons, Ltd.
机译:人胰岛素样生长因子-1(IGF-1)是一种肽激素,可充当生长激素(GH)大部分促生长作用的介质。因此,它被认为是指示运动中GH滥用以及与IGF-1血浆浓度变化有关的疾病的生物标记。它可以通过注射局部应用,以增加组织(例如骨骼肌)中的总蛋白质和DNA含量-在各种体育学科中都是非常理想的效果。为了改善其促进生长的特性,对IGF-1的一级结构进行了修饰,产生了类似物,例如des(1-3)IGF-1和LONG(TM)R-3 IGF-1,它们显示出降低了与血浆中各个结合蛋白的亲和力,从而提高了靶组织的生物利用度。由于它们具有提高性能的能力,IGF-1及其类似物属于世界反兴奋剂机构的禁止清单。因此,有必要开发一种可靠的测定方法来定量人IGF-1及其衍生物。从60μL血浆中进行免疫亲和分离和纯化,然后进行液相色谱/电喷雾串联质谱分析,可以确定所有目标分析物。使用具有高分辨率/高精度特性的Orbitrap质谱仪对诊断产物离子进行表征,并用于三重四极杆MS / MS分析。所描述的测定法提供了20至50 ng / mL的检测下限(LLOD),LLOD的回收率在34-43%之间和精确度<15%,以及更高的浓度水平。为了证明开发的测定方法的适用性,分析了人血浆样品,并将结果与​​从市售免疫放射测定法(IRMA)获得的值进行了比较。六个样品中有四个样品的浓度比在两个试验之间具有良好的相关性,而绝对浓度则相对较低。版权所有(C)2008 John Wiley&Sons,Ltd.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号